Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Resonance HealthASX:RHT +7.69% ROC (Joel Greenblatt) % is 98.99% as of Dec. 2025. The stock has 8 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Resonance Health ranks better than 73.42% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Resonance Health's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 98.99%.
The historical rank and industry rank for Resonance Health's ROC (Joel Greenblatt) % or its related term are showing as below:
ASX:RHT'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -968.63 Med: -234.08 Max: 3400
Current: 30.41
During the past 13 years, Resonance Health's highest ROC (Joel Greenblatt) % was 3400.00%. The lowest was -968.63%. And the median was -234.08%.
ASX:RHT's ROC (Joel Greenblatt) % is ranked better than 73.42% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 12.47
vs ASX:RHT: 30.41
Resonance Health's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
Resonance Health (ASX:RHT) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Resonance Health ROC (Joel Greenblatt) % Related Terms
Resonance Health ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Resonance Health's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:RHT vs VEEV, BTSG, HQY: ROC (Joel Greenblatt) % Comparison
For the Health Information Services subindustry, Resonance Health's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Resonance Health ROC (Joel Greenblatt) % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Resonance Health's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Resonance Health's ROC (Joel Greenblatt) % falls into.
Resonance Health ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 98.99% mean?
Resonance Health (ASX:RHT) has a ROC (Joel Greenblatt) % of 98.99% as of Dec. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Resonance Health and its competitors. According to the industry distribution chart, Resonance Health ranks #177 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 26.6%.
Is Resonance Health's ROC (Joel Greenblatt) % too high?
Resonance Health's current ROC (Joel Greenblatt) % is 98.99%. The Healthcare Providers & Services industry median ROC (Joel Greenblatt) % is 12.47. Resonance Health's value of 98.99% is 693.8% above this industry median. Based on the distribution chart, Resonance Health ranks #177 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint.
How does Resonance Health's ROC (Joel Greenblatt) % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Resonance Health ranks #177 out of 666 companies for ROC (Joel Greenblatt) %. This puts Resonance Health in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 12.47. Resonance Health's value of 98.99% is 693.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Healthcare Providers & Services company?
The median ROC (Joel Greenblatt) % among Healthcare Providers & Services companies is 12.47, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Resonance Health's current ROC (Joel Greenblatt) % of 98.99% is 693.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Resonance Health and its competitors. For the Healthcare Providers & Services industry, the median ROC (Joel Greenblatt) % is 12.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Resonance Health's current ROC (Joel Greenblatt) % is 98.99%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Resonance Health stock overvalued right now?
Based on GuruFocus' analysis, Resonance Health (ASX:RHT) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.12, compared to a current price of A$0.06 — trading 53.3% below its estimated fair value. The current ROC (Joel Greenblatt) % is 98.99% and 693.8% above the Healthcare Providers & Services industry median of 12.47. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Resonance Health (ASX:RHT), the current ROC (Joel Greenblatt) % is 98.99% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Resonance Health Ltd is engaged in the development and commercialisation of software-as-medical-device (SaMD) technologies and services for the quantitative analysis of radiological images in a regulated and quality-controlled environment. The Group's core SaMD product is FerriScan, a non-invasive liver analysis technology used for the assessment of iron in the liver. The Company also has several AI-assisted SaMDs including FerriSmart, HepaFatSmart, and LiverSmart. Its business segments are; SaMD1 which derives key revenue, Corporate, TrialsWest, and Resonance Clinica. Geographically, it generates maximum revenue from the Asia Pacific region and the rest from North America, and Europe, Middle East and Africa (EMEA) regions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:RHT has been successfully added to your 
